わかもと製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4512/E00928 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/10/04 | 日証協 | 478,225株 | +3.69% | 379,376株 | +43.49% | 567,996株 | -19.2% | 174,600株 | -69.46% |
2024/09/27 | 日証協 | 461,225株 | +31.94% | 264,400株 | +1153.08% | 702,974株 | +46.33% | 571,717株 | +3384.8% |
2024/09/20 | 日証協 | 349,581株 | +3.46% | 21,100株 | -19.19% | 480,398株 | -1.76% | 16,406株 | -65.76% |
2024/09/13 | 日証協 | 337,887株 | +3.59% | 26,112株 | +59.1% | 489,015株 | +6.07% | 47,918株 | +42.33% |
2024/09/06 | 日証協 | 326,181株 | +2.05% | 16,412株 | +45.08% | 461,009株 | -1.74% | 33,668株 | +18.27% |
2024/08/30 | 日証協 | 319,625株 | -0.87% | 11,312株 | -35.17% | 469,153株 | +0.17% | 28,468株 | -14.78% |
2024/08/23 | 日証協 | 322,425株 | -21.65% | 17,450株 | +137.61% | 468,353株 | -10.88% | 33,406株 | +115.52% |
2024/08/16 | 日証協 | 411,525株 | -1.58% | 7,344株 | -42.17% | 525,553株 | -1.79% | 15,500株 | -54.28% |
2024/08/09 | 日証協 | 418,125株 | -5.87% | 12,700株 | -48.72% | 535,153株 | -2.08% | 33,900株 | +143.88% |
2024/08/02 | 日証協 | 444,207株 | -13.38% | 24,764株 | -48.41% | 546,505株 | -6.23% | 13,900株 | -58.51% |
2024/07/26 | 日証協 | 512,807株 | -1.4% | 48,000株 | +196.52% | 582,805株 | -0.29% | 33,500株 | +55.09% |
2024/07/19 | 日証協 | 520,107株 | -5.37% | 16,188株 | -88.45% | 584,505株 | -19.6% | 21,600株 | -79.45% |
2024/07/12 | 日証協 | 549,607株 | +2.14% | 140,144株 | +375.26% | 727,005株 | -11.38% | 105,100株 | -62.38% |
2024/07/05 | 日証協 | 538,107株 | +2.22% | 29,488株 | +92.25% | 820,405株 | +42.93% | 279,400株 | +324.99% |
2024/06/28 | 日証協 | 526,407株 | -0.38% | 15,338株 | -84.7% | 574,005株 | -0.34% | 65,742株 | +98.02% |
2024/06/21 | 日証協 | 528,413株 | +20% | 100,227株 | +364.01% | 575,963株 | -3.66% | 33,200株 | +40.68% |
2024/06/14 | 日証協 | 440,330株 | -30.56% | 21,600株 | +33.43% | 597,863株 | -24.6% | 23,600株 | +68.57% |
2024/06/07 | 日証協 | 634,130株 | +0.3% | 16,188株 | +118.76% | 792,963株 | -0.11% | 14,000株 | +1172.73% |
2024/05/31 | 日証協 | 632,230株 | -8.18% | 7,400株 | -75.25% | 793,863株 | -7.8% | 1,100株 | 0% |
※株式分割は考慮していませんのでご注意ください。
Page Top